Breast Cancer Treatment and Symptoms trials Cancer of breast; Cancer, Breast; Malignant neoplasm of breast; malignant tumor of breast; Mammary cancer; Paget's Disease of Breast
Paget's disease of the breast, also known as Paget's disease of the nipple, is a condition that outwardly may have the appearance of eczema - with skin changes involving the nipple of the breast. Symptoms Usually only affecting one nipple, there may be redness, oozing and crusting, and a sore that does not heal. Causes Paget's disease is caused by breast cancer and is present in about 2% of all breast cancers. It typically results when malignant cells from an underlying carcinoma that ...
Wikipedia - [full article]
Breast Cancer Clinical Trials
- Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
ClinicalTrials.gov Identifier: NCT00086749 - Completed
Breast Cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004205 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; breast cancer in situ; recurrent breast cancer; ductal breast carcinoma; ...
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00080626 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Vaccine Therapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004156 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer
ClinicalTrials.gov Identifier: NCT00074152 - Recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
ClinicalTrials.gov Identifier: NCT00033397 - Recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00088829 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005798 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer; ...
- Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00072319 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004038 - Completed
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00054145 - Completed
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
ClinicalTrials.gov Identifier: NCT00083018 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00066378 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075413 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer; stage IIIA breast cancer
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00080665 - Active, not recruiting
Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00107510 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00074139 - Active, not recruiting
stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00016406 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
ClinicalTrials.gov Identifier: NCT00070031 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00046891 - Active, not recruiting
neurotoxicity; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00005058 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
ClinicalTrials.gov Identifier: NCT00002509 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
ClinicalTrials.gov Identifier: NCT00066547 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
ClinicalTrials.gov Identifier: NCT00003016 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00005822 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer; Male Breast Cancer
- Trastuzumab and Radiation Therapy in Treating Women With Stage III or Stage IV Invasive Primary Cancer of the Breast
ClinicalTrials.gov Identifier: NCT00006109 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
- Trastuzumab, Docetaxel, and Carboplatin in Treating Women with Stage II, Stage III, Or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00118053 - Active, not recruiting
inflammatory breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Paclitaxel and Carboplatin in Treating Women Who are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00096343 - Active, not recruiting
invasive ductal breast carcinoma; invasive lobular breast carcinoma; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; ...
- Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00070564 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00022516 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00068757 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Two Dose Levels of Capecitabine With Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Anthracycline-Based Chemotherapy
ClinicalTrials.gov Identifier: NCT00083200 - Recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Lapatinib and Tamoxifen in Treating Patients with Locally Advanced Or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
ClinicalTrials.gov Identifier: NCT00118157 - Recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00127205 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00131963 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00054301 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; intraductal breast carcinoma; breast cancer in situ
- Capecitabine in Women with Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00148720 - Active, not recruiting
Invasive Breast Carcinoma; Primary Invasive Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage III Breast Cancer
- Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy
ClinicalTrials.gov Identifier: NCT00083044 - Completed
Breast Cancer; breast cancer in situ; stage I breast cancer; lobular breast carcinoma in situ; intraductal breast carcinoma
- Chemoprevention Therapy Plus Surgery in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003099 - Active, not recruiting
stage I breast cancer; ductal breast carcinoma; invasive ductal breast carcinoma; prevention of breast cancer; stage II breast cancer
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00044993 - Completed
Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Chemotherapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00012129 - Completed
stage IIIB breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00045097 - Completed
Male Breast Cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00096057 - Completed
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00002662 - Completed
stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00049114 - Completed
inflammatory breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00028704 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
- Medroxyprogesterone in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
- Radiation Therapy in Treating Patients With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00002873 - Completed
stage I breast cancer; tubular ductal breast carcinoma; invasive ductal breast carcinoma; papillary ductal breast carcinoma; stage II breast cancer; ...
- Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00258349 - Suspended
Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002627 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Adjuvant Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00072020 - Active, not recruiting
bone metastases; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004018 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00002616 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; inflammatory breast cancer; recurrent breast cancer
- Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00026442 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014430 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004172 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00028964 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer; Drug Toxicity
- Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003199 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer
- Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00008034 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00004174 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00022230 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003927 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; stage II breast cancer
- Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00047255 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006120 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer
- Doxorubicin and Paclitaxel in Treating Women Who are Undergoing Surgery For Breast Cancer
ClinicalTrials.gov Identifier: NCT00096291 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00010140 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Erlotinib in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00024219 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003068 - Active, not recruiting
stage IIIB breast cancer; Drug Toxicity; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- ICI 182780 in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Letrozole With or Without CCI-779 in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00061971 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00004925 - Active, not recruiting
stage IIIB breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women With Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00070278 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
ClinicalTrials.gov Identifier: NCT00070252 - Active, not recruiting
inflammatory breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; unspecified adult solid tumor, protocol specific
- Nutrition Intervention in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002564 - Active, not recruiting
prevention of breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00006256 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
ClinicalTrials.gov Identifier: NCT00031811 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage IIIB breast cancer; menopausal symptoms; stage IIIA breast cancer; stage II breast cancer; Quality of Life
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00054418 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Temozolomide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00005054 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00022204 - Active, not recruiting
stage I breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage II breast cancer; Quality of Life; Lymphedema
- Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
- Preoperative Cisplatin in Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
- Neoadjuvant Therapy with Herceptin and Taxol for Breast Cancer
ClinicalTrials.gov Identifier: NCT00136539 - Active, not recruiting
Stage II Breast Cancer; Stage III Breast Cancer; Early Stage Breast Cancer; HER2-positive breast cancer
- Cytoxan, Epirubicin and Capecitabine in Women with Breast Cancer
ClinicalTrials.gov Identifier: NCT00146588 - Active, not recruiting
Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00096109 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Bevacizumab and Trastuzumab (Herceptin®) in Treating Women With Relapsed or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00093535 - Recruiting
recurrent breast cancer; stage IIIC breast cancer; stage IV breast cancer; stage IIIB breast cancer
- Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00068341 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage II breast cancer
- Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00066443 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00088985 - Recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- PET Scans in Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00109785 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Bevacizumab and Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00128674 - Recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00265759 - Recruiting
Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
Resources
- ''''Improving the Health of the Public: Part I'''' (HealthWorld)
- A New Treatment for Hot Flashes: Antidepressants (National Cancer Institute)